Jean-Claude Mas, the head of a French company which sold 300,000 faulty PIP breast implants, has been jailed for four years.
It has replaced cancer as the disease people fear most. A slow descent into dementia frightens people more than almost any other fate.
A charity that was formed to improve the care provided to parents who suffer a stillbirth has launched a film to help education NHS workers.
Bosses at Cardiff and Vale University Health Board revealed the full extent of their findings as the partner of one of the eight patients whose death was "unavoidable", began legal action to find out exactly what happened.
Martyn Rogers, 66, of Newport, died of blood poisoning and acute liver failure in summer 2012 at University Hospital Wales.
His death on July 25 came one week after surgeon Dr Berry carried out the vital operation to remove tumours from his liver.
Lawyers acting for Maria Davies, his partner of 40 years,have launched their own investigation into what happened in the case of Mr Rogers.
A spokesman for Cardiff and Vale University Health Board (UHB) has said it can:
Confirm that a specialist liver surgeon working at the University Hospital of Wales was fully suspended from duty in January 2013 following concerns about the outcomes of some liver patients whilst in his care.
The experienced surgeon was employed by the UHB in February 2011.
The UHB identified concerns about the care and treatment of a number his patients who had undergone liver surgery through its normal monitoring procedures in October 2012.
The surgeon was immediately placed on a period of restricted practice pending the outcome of an internal investigation, which confirmed the UHB's initial concerns and resulted in the surgeon being fully suspended from all duties in January 2013.
He was also referred to the General Medical Council.
The surgeon concerned remains fully suspended.
Concerns about the consultant surgeon, a respected specialist in his field, were first raised through the normal monitoring procedures operating at the health board in October 2012.
Officials identified concerns about the care and treatment of a number of patients who had undergone liver surgery led by the consultant.
As a result Dr Berry was immediately placed on restrictive practice while an internal investigation was carried out.
The findings from that investigation were serious enough for Dr Berry to be fully suspended while he was referred to the General Medical Council.
A team from the Royal College of Surgeons was then also called in and an in depth professional investigation carried out.
It uncovered the eight "avoidable deaths" linked to his surgery at the hospital.
A professional review of 31 of a specialist liver surgeon's patients while with the Cardiff and Vale University Health Board, found that 10 went on to die, and "eight of those 10 deaths were avoidable. "
David Paul Berry, a veteran surgeon, who moved to work in Wales from the Leicester area, was active with the health board for 18 months before he was suspended.
Health chiefs have suspended a specialist liver surgeon linked to the "avoidable deaths" of eight patients he operated on in South Wales.
Consultant surgeon David Paul Berry, based at University Hospital Wales, has been banned by the General Medical Council (GMC) from doing any further liver surgery.
The Cardiff and Vale University Health Board has suspended a specialist liver surgeon linked to the "avoidable deaths" of eight patients he operated on in South Wales.
One of the 47,000 British women who received faulty PIP breast implants recalls the terrifying experience of finding her implant had ruptured.
Emma Lonsdale, 31, says she was '"absolutely petrified" when she found a lump in one of her breasts.
In Implant patient said she was disgusted over the four year sentence handed down to Jean-Claude Mas, the boss of a French company which sold 300,000 faulty PIP breast implants.
Leesa Goodway from Wickwar, South Gloucestershire, said: "I think it is disgusting when you think about the number of people that were affected by this.
"You've got the health issues, the mental issues, the financial burden, not just on the people who were forced to pay to have a replacement, like myself, [but also] the financial burden on the companies.
"I just don't think the sentence of four years equates to the distress, and all the heartache that was caused by someone basically profiteering and trying to make money."
Four other executives responsible for selling PIP breast implants, were sentenced alongside the company's founder and long-time chief executive Jean-Claude Mas.
The four received sentences between one and a half and three years in prison, some of it suspended, and ordered to pay fine.
"It's a strong signal. This decision is what victims were waiting for," said one of their lawyers, Philippe Courtois.